Transposagen Biopharmaceuticals

About:

Transposagen Biopharmaceuticals provides animal models of human diseases for drug discovery and development.

Website: http://www.transposagenbio.com

Twitter/X: transposagen

Description:

Transposagen Biopharmaceuticals is a privately held biotechnology company that is dedicated to providing unique animal models of human diseases for drug discovery and development. Transposagen is currently focusing on the $1.2 billion/year rodent model market. The rodent model market is experiencing double-digit annual growth due to the research and development needs of the pharmaceutical industry. It was founded in 2003 and is headquartered in Lexington, Kentucky.

Total Funding Amount:

$6.67M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lexington, Kentucky, United States

Founded Date:

2003-10-23

Contact Email:

info(AT)transposagenbio.com

Founders:

Eric Ostertag

Number of Employees:

11-50

Last Funding Date:

2015-02-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai